Design Therapeutics, Inc.
DSGN
$5.41
$0.214.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 216.28M | 229.67M | 245.48M | 254.07M | 261.02M |
| Total Receivables | 1.35M | 1.41M | 1.26M | 1.18M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.17M | 2.57M | 1.30M | 1.99M | 2.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 219.79M | 233.64M | 248.04M | 257.24M | 264.84M |
|
|
|||||
| Total Current Assets | 219.79M | 233.64M | 248.04M | 257.24M | 264.84M |
| Net Property, Plant & Equipment | 3.09M | 3.40M | 3.63M | 3.96M | 4.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 427.00K | 427.00K | 427.00K | 429.00K |
| Total Assets | 222.89M | 237.48M | 252.09M | 261.63M | 269.58M |
|
|
|||||
| Total Accounts Payable | 1.01M | 3.18M | 2.19M | 1.47M | 1.30M |
| Total Accrued Expenses | 6.89M | 4.24M | 5.48M | 5.18M | 4.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 844.00K | 821.00K | 800.00K | 778.00K | 757.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.75M | 8.24M | 8.46M | 7.43M | 6.39M |
|
|
|||||
| Total Current Liabilities | 8.75M | 8.24M | 8.46M | 7.43M | 6.39M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.10M | 1.32M | 1.53M | 1.74M | 1.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.85M | 9.56M | 10.00M | 9.18M | 8.34M |
|
|
|||||
| Common Stock & APIC | 476.74M | 472.40M | 468.84M | 465.10M | 461.98M |
| Retained Earnings | -264.01M | -244.93M | -227.21M | -213.56M | -200.52M |
| Treasury Stock & Other | 305.00K | 450.00K | 475.00K | 914.00K | -217.00K |
| Total Common Equity | 213.04M | 227.92M | 242.10M | 252.45M | 261.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 213.04M | 227.92M | 242.10M | 252.45M | 261.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 213.04M | 227.92M | 242.10M | 252.45M | 261.24M |
|
|
|||||